Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Statin Therapy to Reduce Disease Progression From Liver Cirrhosis to Cancer

NCT02968810 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT02968810
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02968810 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Statin Therapy to Reduce Disease Progression From Liver Cirrhosis to Cancer
Lead sponsor
National Cancer Institute (NCI)
Phase
Phase 2
Overall status
Completed
Start date
June 21, 2017
Completion date
July 7, 2026
Enrollment
52 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

cirrhosis, hepatocellular carcinoma